Mission to Revolutionise Bone Health with Advanced Echolight Technology

Gary Rhodes, founder of Screen My Bones®, is on a mission to revolutionise the way we think about and improve bone health. With a firm belief that musculoskeletal wellness should be routinely monitored as a key biomarker of health span, he is driving a movement towards preventative, proactive bone screening over reactive treatments.

Osteoporosis and poor bone health affect millions worldwide, yet bone density checks are rarely prioritised until later life. For decades, bone density checks have been reserved for older adults, leaving millions at risk of fractures before any intervention is made. 

Rhodes aims to change this mindset, advocating for early screening from as young as the 20s and 30s, ensuring individuals can take action before bone deterioration begins. At the core of this initiative is Echolight REMS technology, a groundbreaking, radiation-free alternative to traditional bone density scans. This innovation makes frequent, safe, and accessible bone assessments a reality for everyone.

Traditional bone density assessments, such as Dual-Energy X-ray Absorptiometry (DEXA) scans, primarily measure bone mineral density (BMD) but often overlook critical factors like bone quality and structural integrity. This limitation can lead to false diagnoses of osteoporosis, where individuals with lower BMD but robust bone quality are unnecessarily subjected to treatments and medications that may adversely affect their bone health further. Furthermore, DEXA scans may not accurately reflect fracture risk in patients with degenerative changes or those treated with corticosteroids (*).

Echolight REMS technology addresses these shortcomings by providing a comprehensive evaluation of bone health, integrating both BMD and bone quality assessments. This holistic approach significantly reduces the risk of false diagnoses and ensures that only individuals truly at risk receive medical interventions. 

Additionally, Echolight’s radiation-free methodology allows for safe, repeated assessments, facilitating continuous monitoring and timely lifestyle modifications to enhance bone strength. This means individuals – whether athletes, postmenopausal women, or those with genetic predispositions – can monitor and improve their bone health safely and effectively.

Why This Matters:
3.5 million people in the UK are affected by osteoporosis (**).
520,000 fragility fractures occur annually (***).
50% of women and 20% of men over 50 will suffer fractures due to reduced bone strength (****).

Bone health is intrinsically linked to overall health. Bones provide structure, protect organs, anchor muscles, and store calcium. They play a crucial role in movement, support, and protecting vital organs like the heart and lungs. Moreover, bones serve as a reservoir for minerals essential for various bodily functions, including nerve transmission and muscle contraction. Maintaining bone health is vital not only to prevent osteoporosis but also to ensure overall physiological well-being.

A recognised leader in skeletal health innovation, Gary Rhodes is at the forefront of bridging gaps in musculoskeletal healthcare. He works alongside top scientists, medical experts, and wellness pioneers to reshape how bone health is understood, assessed, and optimised. His work spans corporate wellness, clinical research, and healthcare technology to drive real-world impact in preventing osteoporosis and improving bone health outcomes globally.

His mission is built on the belief that we don’t just have an obesity crisis – we have a skeletal health crisis. Many people today are under-muscled, under-boned, and under-nourished. However, Osteoporosis and poor bone health are not inevitable consequences of aging – they can be a choice, influenced by lifestyle, nutrition, and proactive monitoring.

Rhodes has collaborated with some of the biggest names in health and performance, including Grant Cardone, Gary Brecka, Brandon Dawson, Tony Robbins, GCH Partners, Powerplate, Alvarez – Ultra Athlete, Liver Clinic, Mayfair Health, MBST, Ben Greenfield, Dave Asprey, Tim Gray, Anthea Turner, and Davinia Taylor.

Gary Rhodes, Founder of Screen My Bones, says: “Bone health is the foundation of longevity. At Screen My Bones, we’re not just screening – we’re setting a new global standard for prevention, giving people the power to strengthen their future before fractures define it.”

Dr Nick Birch, Trauma & Orthopaedic Surgeon, says: “Having conducted over 3,500 Echolight scans, I have seen firsthand how this groundbreaking technology is revolutionising bone health. For the first time, we can proactively assess bone quality with precision, without radiation, and at an earlier stage – allowing us to shift from reactive treatment to true prevention. This is the future of osteoporosis care.”

Echolight screenings will be available at Harley Street Longevity Club, London from April. To find a screening clinic near you please visit: https://www.screenmybones.com/find-a-screening-centre